2.48
price down icon4.98%   -0.13
pre-market  プレマーケット:  2.48  
loading

C 4 Therapeutics Inc (CCCC) 最新ニュース

pulisher
Nov 03, 2025

Karyopharm Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Akebia Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Aardvark Therapeutics (Nasdaq: AARD) grants inducement options totaling 88,217 shares - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 03, 2025
pulisher
Nov 03, 2025

Xilio Therapeutics (Nasdaq: XLO) grants inducement option at $0.7967 with 10-year term - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WV News

Nov 03, 2025
pulisher
Nov 03, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 03, 2025
pulisher
Nov 02, 2025

C4 Therapeutics Inc. stock trend forecastNew Guidance & High Accuracy Trade Signal Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Volatility clustering patterns for C4 Therapeutics Inc.Earnings Overview Summary & Safe Entry Point Identification - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will earnings trigger a reversal in C4 Therapeutics Inc.Product Launch & Low Risk Investment Opportunities - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

C4 Therapeutics Inc Stock Analysis and ForecastSupport Zone Identification & Investor Community Interactions - earlytimes.in

Nov 01, 2025
pulisher
Oct 31, 2025

C4 Therapeutics Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 30, 2025

RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in C4 The - GuruFocus

Oct 30, 2025
pulisher
Oct 28, 2025

How strong is C4 Therapeutics Inc. stock balance sheet2025 Buyback Activity & Technical Pattern Based Buy Signals - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Oct 28, 2025
pulisher
Oct 28, 2025

What hedge fund activity signals for C4 Therapeutics Inc. stockMarket Movers & Low Drawdown Investment Ideas - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Ptc therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Oct 27, 2025
pulisher
Oct 27, 2025

C4 Therapeutics Inc. stock retracement – recovery analysisMarket Performance Summary & Proven Capital Preservation Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How C4 Therapeutics Inc. stock benefits from strong dollarJuly 2025 Market Mood & Safe Entry Point Alerts - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Full technical analysis of C4 Therapeutics Inc. stockQuarterly Profit Report & Real-Time Volume Analysis Alerts - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

C4 Therapeutics (NASDAQ:CCCC) Given Sell (D-) Rating at Weiss Ratings - MarketBeat

Oct 25, 2025
pulisher
Oct 24, 2025

C4 Therapeutics, Inc. (NASDAQ:CCCC) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Oct 24, 2025
pulisher
Oct 23, 2025

How C4 Therapeutics Inc. stock reacts to oil pricesEarnings Overview Summary & Community Consensus Picks - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

C4 Therapeutics (CCCC) Expected to Announce Earnings on Thursday - MarketBeat

Oct 23, 2025
pulisher
Oct 21, 2025

Applying chart zones and confluence areas to C4 Therapeutics Inc.2025 Big Picture & Breakout Confirmation Trade Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 21, 2025
pulisher
Oct 21, 2025

Live market analysis of C4 Therapeutics Inc.2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Candlestick signals on C4 Therapeutics Inc. stock todayJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

Will C4 Therapeutics Inc. stock benefit from commodity pricesEarnings Risk Report & Low Risk High Win Rate Stock Picks - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025
pulisher
Oct 17, 2025

Will C4 Therapeutics Inc. stock maintain momentum in 20252025 Price Targets & Community Consensus Trade Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

CEO Moves: Will C4 Therapeutics Inc. stock maintain momentum in 2025Weekly Profit Analysis & Weekly Consistent Profit Watchlists - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

C4 Therapeutics Lines Up $125 Million To Fund Cancer Trials - Finimize

Oct 17, 2025
pulisher
Oct 17, 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record

Oct 17, 2025
pulisher
Oct 16, 2025

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - PharmiWeb.com

Oct 16, 2025
pulisher
Oct 16, 2025

C4 Therapeutics Announces Stock and Warrants Offering - TipRanks

Oct 16, 2025
pulisher
Oct 16, 2025

Revenues Working Against C4 Therapeutics, Inc.'s (NASDAQ:CCCC) Share Price Following 38% Dive - 富途牛牛

Oct 16, 2025
pulisher
Oct 16, 2025

C4 Therapeutics (CCCC) to Raise $125M Through Stock and Warrant Offering - GuruFocus

Oct 16, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
大文字化:     |  ボリューム (24 時間):